233 related articles for article (PubMed ID: 35178322)
1. Assessment of Stability of Prothrombin Time, International Normalized Ratio, and Activated Partial Thromboplastin Time Under Different Storage Conditions in Human Plasma.
Patil P; Sehgal T; Goswami P; Gaur M; Khan M; Pandey S; Datta SK
Cureus; 2022 Jan; 14(1):e21268. PubMed ID: 35178322
[TBL] [Abstract][Full Text] [Related]
2. Stability of prothrombin time and activated partial thromboplastin time tests under different storage conditions.
Rao LV; Okorodudu AO; Petersen JR; Elghetany MT
Clin Chim Acta; 2000 Oct; 300(1-2):13-21. PubMed ID: 10958859
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Citrated Plasma After Thawing for Routine Coagulation Testing.
Reddy S; Sehgal T; Rathod G; Prabhala S; Kamble P; Shekhar S; Patil P
Cureus; 2023 Jun; 15(6):e40023. PubMed ID: 37425605
[TBL] [Abstract][Full Text] [Related]
4. Impact of different storage times at room temperature of unspun citrated blood samples on routine coagulation tests results. Results of a bicenter study and review of the literature.
Toulon P; Metge S; Hangard M; Zwahlen S; Piaulenne S; Besson V
Int J Lab Hematol; 2017 Oct; 39(5):458-468. PubMed ID: 28481034
[TBL] [Abstract][Full Text] [Related]
5. Standardization of coagulation tests.
Opartkiattikul N
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
[TBL] [Abstract][Full Text] [Related]
6. Variability in international normalized ratio and activated partial thromboplastin time after injury are not explained by coagulation factor deficits.
Stettler GR; Moore EE; Moore HB; Nunns GR; Coleman JR; Colvis A; Ghasabyan A; Cohen MJ; Silliman CC; Banerjee A; Sauaia A
J Trauma Acute Care Surg; 2019 Sep; 87(3):582-589. PubMed ID: 31136528
[TBL] [Abstract][Full Text] [Related]
7. Is it acceptable to use coagulation plasma samples stored at room temperature and 4°C for 24 hours for additional prothrombin time, activated partial thromboplastin time, fibrinogen, antithrombin, and D-dimer testing?
Rimac V; Coen Herak D
Int J Lab Hematol; 2017 Oct; 39(5):475-481. PubMed ID: 28488785
[TBL] [Abstract][Full Text] [Related]
8. Effect of artificial colloids on blood coagulation during shock stage of severe burn injury.
Zhou JJ; Xing N; Chen J; Shi JW; Su GL
Chin Med J (Engl); 2013; 126(17):3334-9. PubMed ID: 24033960
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of routine coagulation tests for patients with heat stroke.
Xing L; Liu SY; Mao HD; Zhou KG; Song Q; Cao QM
Am J Emerg Med; 2021 Jun; 44():366-372. PubMed ID: 32389399
[TBL] [Abstract][Full Text] [Related]
10. Comparability of the results of PT-INR with local MNPT and APTTR with MNAPTT on different coagulation analyzers in China.
Peng L; Yan C; Wu X; Nie L
Int J Lab Hematol; 2009 Jun; 31(3):352-8. PubMed ID: 18510575
[TBL] [Abstract][Full Text] [Related]
11. Comparison of five point-of-care prothrombin and activated partial thromboplastin time devices based on age of blood sample.
Searles B; Nasrallah F; Graham S; Lajara RB
J Extra Corpor Technol; 2002 Sep; 34(3):178-81. PubMed ID: 12395962
[TBL] [Abstract][Full Text] [Related]
12. Effect of isotretinoin on prothrombin time (PT), international normalized ratio (INR), and activated partial thromboplastin time (aPTT).
Kaptanoglu AF; Uncu M; Ozyurt S; Hincal E
J Dermatolog Treat; 2013 Aug; 24(4):272-4. PubMed ID: 22188511
[TBL] [Abstract][Full Text] [Related]
13. Stability of plasma for add-on PT and APTT tests.
Neofotistos D; Oropeza M; Ts'ao CH
Am J Clin Pathol; 1998 Jun; 109(6):758-63. PubMed ID: 9620036
[TBL] [Abstract][Full Text] [Related]
14. Effects of storage time and temperature on coagulation tests and factors in fresh plasma.
Feng L; Zhao Y; Zhao H; Shao Z
Sci Rep; 2014 Jan; 4():3868. PubMed ID: 24463857
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity and specificity of 20-minute whole blood clotting test, prothrombin time, activated partial thromboplastin time tests in diagnosis of defibrination following Malayan pit viper envenoming.
Thongtonyong N; Chinthammitr Y
Toxicon; 2020 Oct; 185():188-192. PubMed ID: 32712023
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Analytical Properties of the Diagon CoagXL Coagulation Analyzer.
Koç H; Yildiz Z; Hürmeydan Ö; Madenci ÖÇ; Yücel N; Orçun A
Clin Lab; 2019 Jun; 65(6):. PubMed ID: 31232028
[TBL] [Abstract][Full Text] [Related]
17. Effects of sugammadex on activated partial thromboplastin time and prothrombin time in healthy subjects.
De Kam PJ; Grobara P; Prohn M; Höppener F; Kluft C; Burggraaf J; Langdon RB; Peeters P
Int J Clin Pharmacol Ther; 2014 Mar; 52(3):227-36. PubMed ID: 24447651
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of the factors associated with abnormal coagulation and prognosis
in patients with non-small cell lung cancer].
Li Y; Wei S; Wang J; Hong L; Cui L; Wang C
Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):789-96. PubMed ID: 25404269
[TBL] [Abstract][Full Text] [Related]
19. Determining the maximal storage time of centrifuged citrated samples for performing add-on routine coagulation tests.
Denessen EJS; Jeurissen MLJ; Pereboom RMTA; Verhezen PWM; Henskens YMC
Thromb Res; 2020 Dec; 196():54-62. PubMed ID: 32841921
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a point-of-care coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and activated clotting time in dogs.
Tseng LW; Hughes D; Giger U
Am J Vet Res; 2001 Sep; 62(9):1455-60. PubMed ID: 11560277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
